Concepedia

Author

Burcu Aslan

The University of Texas MD Anderson Cancer Center

Also Known As

Burcu Aslan

166

Publications

1.4K

Citations

16

H-Index

24

Concepts

All Affiliations

The University of Texas MD Anderson Cancer CenterHouston MethodistAl-Azhar UniversityGaziantep UniversityInstituto Politécnico Nacional
BA

About

Burcu Aslan is an author at The University of Texas MD Anderson Cancer Center specializing in cell biology, medicine, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

98

2

Cell Biology

3

3

98

3

Engineering

1

1

23

4

Biomedical Engineering

1

1

23

5

Immunology

1

1

20

Burcu Aslan

×

15

Publications

1.2K

Citations

15

H-Index

YearCitations

Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer

Pınar Kanlikilicer, Recep Bayraktar, Merve Denizli,

EBioMedicine

2018

215

MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase

Recep Bayraktar, Martin Pichler, Pınar Kanlikilicer,

Oncotarget

2016

152

Ubiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells

Pınar Kanlikilicer, Mohammed H. Rashed, Recep Bayraktar,

Cancer Research

2016

138

Enhancing Chemotherapy Response with Sustained EphA2 Silencing Using Multistage Vector Delivery

Haifa Shen, Cristian Rodriguez‐Aguayo, Rong Xu,

Clinical Cancer Research

2013

107

Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models

Pınar Kanlikilicer, Bülent Özpolat, Burcu Aslan,

Molecular Therapy — Nucleic Acids

2017

78

Rac1/Pak1/p38/MMP-2 Axis Regulates Angiogenesis in Ovarian Cancer

Vianey González-Villasana, Enrique Fuentes‐Mattei, Cristina Ivan,

Clinical Cancer Research

2015

75

Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAs

Mohammed H. Rashed, Pınar Kanlikilicer, Cristian Rodriguez‐Aguayo,

Oncotarget

2017

68

PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis

Cristian Rodriguez‐Aguayo, Emine Bayraktar, Cristina Ivan,

EBioMedicine

2019

64

AMG-176, an Mcl-1 Antagonist, Shows Preclinical Efficacy in Chronic Lymphocytic Leukemia

Yi Xue, Aloke Sarkar, Burcu Aslan,

Clinical Cancer Research

2020

62

The ZNF304-integrin axis protects against anoikis in cancer

Burcu Aslan, Paloma del C. Monroig, Ming‐Chuan Hsu,

Nature Communications

2015

60

Page 1